drugset / Trial / NCT02157506
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, double-blinded, placebo-controlled study of continuous 6-hour IV infusions of CXL-1427 in hospitalized patients with systolic heart failure.
Timeline
- Start
- 2014-06-30
- Primary completion
- 2015-05-31
- Completion
- 2015-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cimlanod | Other / unclassified | 3 ug/kg | Intravenous |